These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9710712)

  • 21. Persistent vaginal bleeding in a patient with a broken Implanon.
    Pickard S; Bacon L
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):207-8. PubMed ID: 12419064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implanon. The new alternative.
    Cherry S
    Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.
    Dieben TO; Roumen FJ; Apter D
    Obstet Gynecol; 2002 Sep; 100(3):585-93. PubMed ID: 12220783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Norplant implants among Thai women in Bangkok.
    Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implanon: a critical review.
    Le J; Tsourounis C
    Ann Pharmacother; 2001 Mar; 35(3):329-36. PubMed ID: 11261531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
    Bennink HJ
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acceptability of the etonogestrel-containing contraceptive implant (Implanon)].
    Sergent F; Clamageran C; Bastard AM; Verspyck E; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2004 Sep; 33(5):407-15. PubMed ID: 15480280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
    Roumen FJ; Apter D; Mulders TM; Dieben TO
    Hum Reprod; 2001 Mar; 16(3):469-75. PubMed ID: 11228213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One year study of Implanon on the adverse events and discontinuation.
    Chaovisitsaree S; Piyamongkol W; Pongsatha S; Morakote N; Noium S; Soonthornlimsiri N
    J Med Assoc Thai; 2005 Mar; 88(3):314-7. PubMed ID: 15962637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable contraception.
    Darney PD
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():2-11. PubMed ID: 11246603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of Implanon on menstrual bleeding patterns.
    Mansour D; Korver T; Marintcheva-Petrova M; Fraser IS
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():13-28. PubMed ID: 18330814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
    Roumen F
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implanon: subdermal single rod contraceptive implant.
    Bhatia P; Nangia S; Aggarwal S; Tewari C
    J Obstet Gynaecol India; 2011 Aug; 61(4):422-5. PubMed ID: 22851825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.